Article Information
History
- July 27, 2020.
Article Versions
- Version 1 (May 10, 2020 - 16:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Per Nilsson1,2,*,†,
- Karin Sörgjerd1,†,
- Naomasa Kakiya1,†,
- Hiroki Sasaguri1,†,
- Naoto Watamura1,†,
- Makoto Shimozawa2,
- Satoshi Tsubuki1,
- Zhulin Zhou2,
- Raul Loera-Valencia2,
- Risa Takamura1,
- Misaki Sekiguchi1,
- Aline Petrich3,
- Stefan Schulz3,
- Takashi Saito1,4,
- Bengt Winblad2,5 and
- Takaomi C. Saido1,*
- 1Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- 2Karolinska Institutet, Dept. of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division for Neurogeriatrics, 171 64, Solna, Sweden
- 3Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich-Schiller University, 07747, Jena, Germany
- 4Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Aichi, Japan
- 5Karolinska University Hospital, Theme aging, 141 57, Huddinge, Sweden
- ↵*Corresponding authors: E-mail: per.et.nilsson{at}ki.se, saido{at}brain.riken.jp
↵† Equal contribution